Literature DB >> 1549775

The ability of certain SIV vaccines to provoke reactions against normal cells.

A J Langlois1, K J Weinhold, T J Matthews, M L Greenberg, D P Bolognesi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1549775     DOI： 10.1126/science.1549775

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  16 in total

1.  AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: reevaluation of neutralizing antibody levels elicited by a protective and a nonprotective vaccine after removal of antisubstrate cell antibodies.

Authors:  S Giannecchini; D Del Mauro; D Matteucci; M Bendinelli
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1.

Authors:  Yun Kenneth Kang; Sofija Andjelic; James M Binley; Emma T Crooks; Michael Franti; Sai Prasad N Iyer; Gerald P Donovan; Antu K Dey; Ping Zhu; Kenneth H Roux; Robert J Durso; Thomas F Parsons; Paul J Maddon; John P Moore; William C Olson
Journal:  Vaccine       Date:  2009-06-28       Impact factor: 3.641

3.  Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity.

Authors:  K S Cole; J L Rowles; B A Jagerski; M Murphey-Corb; T Unangst; J E Clements; J Robinson; M S Wyand; R C Desrosiers; R C Montelaro
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Generation of CD8 suppressor factor and beta chemokines, induced by xenogeneic immunization, in the prevention of simian immunodeficiency virus infection in macaques.

Authors:  Y Wang; L Tao; E Mitchell; W M Bogers; C Doyle; C A Bravery; L A Bergmeier; C G Kelly; J L Heeney; T Lehner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

5.  Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies.

Authors:  D Matteucci; M Pistello; P Mazzetti; S Giannecchini; D Del Mauro; L Zaccaro; P Bandecchi; F Tozzini; M Bendinelli
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

6.  Cytoskeletal proteins bound to heat-shock protein 70 may elicit resistance to simian immunodeficiency virus infection of CD4(+) T cells.

Authors:  Lesley A Bergmeier; Kaboutar Babaahmady; Jeffrey Pido-Lopez; Kate J Heesom; Charles G Kelly; Thomas Lehner
Journal:  Immunology       Date:  2009-11-25       Impact factor: 7.397

7.  Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines.

Authors:  Z R Israel; P F Edmonson; D H Maul; S P O'Neil; S P Mossman; C Thiriart; L Fabry; O Van Opstal; C Bruck; F Bex
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal portal of entry.

Authors:  A B Sabin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

Review 9.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

10.  Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus.

Authors:  J K Yamamoto; T Hohdatsu; R A Olmsted; R Pu; H Louie; H A Zochlinski; V Acevedo; H M Johnson; G A Soulds; M B Gardner
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.